Disease Synopsis
Overview
Drugs and Clinical Candidates
Clinical Trials (visual)
Clinical Trials (text)
Cell Line Models
Chemistry

Soft Tissue Cancer - Overview - Disease Synopsis

Drugs & Clinical Candidates


12 drugs have received FDA approval for Soft Tissue Cancer . Dactinomycin, Doxorubicin Hydrochloride, Eribulin Mesylate, Imatinib Mesylate, Methotrexate Sodium, Olaratumab, Paclitaxel, Pazopanib Hydrochloride, Recombinant Interferon Alfa-2b, Trabectedin, Vinblastine Sulfate and Vincristine Sulfate
314 drugs have a clinical trial registered for Soft Tissue Cancer.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Clinical Trials


There are 1447 clinical trials for Soft Tissue Cancer,
948 of which have one or more drug interventions,
499 with no drug intervention.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Cell Line Models


There are 351 Cell Line Models for Soft Tissue Cancer.

Source: COSMIC
(see details)

Chemistry


There are 2883 Compounds which have been tested in Soft Tissue Cancer , 2101 <= 500nM potency.

Source: ChEMBL
(see details)

Mappings


Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Soft Tissue Cancer:
Adenosarcoma
Carcinosarcoma
Chondrosarcoma
Chondrosarcoma, Mesenchymal
Dermatofibrosarcoma
Fibrosarcoma
Gliosarcoma
Glomus Tumor
Hemangiosarcoma
Histiocytic Sarcoma
Leiomyosarcoma
Liposarcoma
Liposarcoma, Myxoid
Lymphangiosarcoma
Mast-Cell Sarcoma
Myosarcoma
Neoplasms, Connective and Soft Tissue
Neurofibrosarcoma
Osteosarcoma
Rhabdomyosarcoma
Rhabdomyosarcoma, Alveolar
Rhabdomyosarcoma, Embryonal
Sarcoma
Sarcoma, Alveolar Soft Part
Sarcoma, Clear Cell
Sarcoma, Endometrial Stromal
Sarcoma, Ewing
Sarcoma, Kaposi
Sarcoma, Myeloid
Sarcoma, Synovial
Soft Tissue Neoplasms

The following terms have been mapped from cancer.gov to Soft Tissue Cancer:
AIDS-related Kaposi sarcoma
AIDS-related Kaposi sarcoma that has gotten worse after treatment with other chemotherapy, or in patients who are not able to use other drugs
AIDS-related Kaposi sarcoma. It is used in certain adults who do not have many symptoms of the disease
Dermatofibrosarcoma protuberans
Ewing sarcoma
Kaposi sarcoma
Liposarcoma (a type of soft tissue sarcoma) that cannot be removed by surgery or has metastasized. It is used in patients who have already been treated with anthracycline chemotherapy
Liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have metastasized (spread to other parts of the body). It is used in patients who have already been treated with anthracycline chemotherapy
Osteosarcoma that has not spread to other parts of the body. It is used following surgery to remove the primary tumor
Rhabdomyosarcoma
Rhabdomyosarcoma in children
Soft tissue and bone sarcomas
Soft tissue sarcoma that cannot be cured with surgery or radiation therapy. It is used in adults with soft tissue sarcoma that has not already been treated with an anthracycline drug, such as doxorubicin
Soft tissue sarcoma that is advanced. It is used in patients who have already been treated with chemotherapy